The struggle to get hold of medication in England is set to get worse

The struggle to get hold of medication in England is set to get worse

Chloe Hayward, reporting on the current health crisis, highlights the growing difficulty many patients in England face in obtaining essential medications. One such patient, Chloe, 29, who lives with epilepsy, expresses deep anxiety over the shortages, describing her experience as “just terrifying” and admitting she suffers panic attacks. Her key medication, Lamotrigine, vital in preventing her life-threatening seizures, has become increasingly difficult to find. Although she can access some of her other prescriptions without issue, it is this particular drug that is crucial for her everyday safety and ability to work, yet remains elusive.

The scarcity of medicines is not isolated to epilepsy patients. Across England, individuals managing a wide range of health conditions, including heart disease, stroke risk, eye infections, bipolar disorder, and ADHD, are encountering similar challenges in securing their prescribed treatments. Pharmacies nationwide frequently face supply shortages, leaving many people empty-handed despite their need. Experts attribute these shortages partly to rising global prices but also to the complexities within the UK’s medicine funding and reimbursement system. Essentially, the NHS compensates pharmacies a fixed price for dispensed medicines, yet when drug prices spike, pharmacies may find themselves dispensing at a loss.

This price disparity results in a growing number of medications being listed on the government’s price concessions list, which permits pharmacies reimbursement at higher costs. Yet, rapid market price increases sometimes exceed even these concessions, pressuring pharmacies financially and limiting stock availability. Pharmacists like Akash Patel from Surrey share firsthand difficulties, such as having to supply epilepsy medications at a loss, leading to reduced stock levels that adversely affect patient access. Over the past seven years, a significant reduction in the number of High Street pharmacies has occurred, with closures linked to these financial strains. Patel describes the current challenges as “the worst I’ve ever known it.”

Patients face ongoing stress in navigating this shortage. For example, Chris Henry, who manages Parkinson’s Disease with a medication also on the concessions list, voices his concern over the uncertainty, noting that without these drugs, his symptoms would worsen significantly. Meanwhile, pharmacists report having to order minimal quantities of costly drugs to manage financial risks, with no assurance that supplies will even arrive. The broader context reveals that the UK spends comparatively less on medicines than neighboring European countries, diminishing its attractiveness as a market for manufacturers. Pharmacy owners have resorted to personal sacrifices, such as remortgaging homes, to keep their businesses afloat. Industry experts warn systemic reform is necessary to address the slow response to price surges and to ensure more reliable medication supply, emphasizing that the current model is unsustainable and ultimately harms patients the most

Read the full article from The BBC here: Read More